Potassium Bitartrate
Active ingredient
Sold as Phexx · Phexxi · CEO-TWO
- Drug class
- -
- Availability
- Prescription and OTC
- Routes
- Rectal, Vaginal
- Markets covered
- 1
- Products on record
- 3
- FDA reports (12 mo)
- 7
Overview
Plain-language summary, compiled from the cited regulatory records
Potassium bitartrate is used for the relief of occasional constipation [1]. This product typically produces a bowel movement within 5 to 30 minutes [1].
Potassium bitartrate is available under several brand names, including CEO-TWO, Phexx, and Phexxi [1]. In the past 12 months, there have been 7 adverse event reports associated with this active ingredient [2]. The most frequently reported adverse events include complication of device insertion, abdominal pain, heavy menstrual bleeding, abdominal distension, and back pain [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 3 | November 5, 2025 |
USUnited States· FDA
3 products
Uses
Uses for relief of occasional constipation this product generally produces a bowel movement in 5 to 30 minutes
How to take
Sources & citations
- [1]FDA DailyMed · 08670636-5795-4d… · revised November 5, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.